Merck & Co Inc (TSX:MRK)
C$ 28.29 -0.030 (-0.11%) Market Cap: 441.77 Bil Enterprise Value: 503.48 Bil PE Ratio: 35.49 PB Ratio: 6.78 GF Score: 64/100

Q1 2025 Merck & Co Inc Earnings Call Transcript

Apr 24, 2025 / 01:00PM GMT
Release Date Price: C$18.28 (+0.88%)
Operator

Thank you for standing by. Welcome to the Merck & Co., Inc., Rahway, New Jersey, USA quarter one sales and earnings conference call. (Operator Instructions) This call is being recorded. If you have any objections, you may disconnect at this time.

I would like to turn the call to Mr. Dannenbaum, Senior Vice President, Investor Relations. Sir, you may begin.

Peter Dannenbaum
Merck & Co Inc., Rahway, N.J., USA - Senior Vice President, Investor Relations

Thank you, Dustin, and good morning, everyone. Welcome to the first quarter 2025 conference call for Merck & Co., Inc. Rahway, New Jersey, USA. Speaking on today's call will be Rob Davis, Chairman and Chief Executive Officer; Caroline Litchfield, Chief Financial Officer; and Dr. Dean Li, President of Research Labs.

Before we get started, I'd like to point out that we have items in our GAAP results, acquisition-related charges, restructuring costs, and certain other items, that we have excluded from our non-GAAP results.

There is a reconciliation in our press release. I will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot